Insider Transactions in Q2 2022 at Opiant Pharmaceuticals, Inc. (OPNT)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2022
|
Matthew R. Ruth Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+6.06%
|
-
|
|
Jun 27
2022
|
Brian Gorman |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+5.49%
|
-
|
|
Jun 27
2022
|
Phil Skolnick Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+7.56%
|
-
|
|
Jun 27
2022
|
David D O'Toole Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+5.05%
|
-
|
|
Jun 27
2022
|
Roger Crystal Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,667
+7.26%
|
-
|
|
Jun 27
2022
|
Mark Jason Heath Ellison Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+8.46%
|
-
|
|
Jun 15
2022
|
Michael Sinclair Director |
SELL
Open market or private sale
|
Direct |
900
-4.47%
|
$9,000
$10.6 P/Share
|
|
Jun 14
2022
|
Michael Sinclair Director |
SELL
Open market or private sale
|
Direct |
7,225
-26.42%
|
$72,250
$10.9 P/Share
|
|
Jun 14
2022
|
Thomas T. Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+13.91%
|
-
|
|
Jun 14
2022
|
Gabrielle Alison Silver Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+7.89%
|
-
|
|
Jun 14
2022
|
Ann L. Mac Dougall Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+6.63%
|
-
|
|
Jun 14
2022
|
Masuoka K. Lorianne Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+33.33%
|
-
|
|
Jun 14
2022
|
Richard J Daly Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+20.41%
|
-
|
|
Jun 14
2022
|
Craig A Collard Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+3.46%
|
-
|
|
Jun 13
2022
|
Michael Sinclair Director |
SELL
Open market or private sale
|
Direct |
5,491
-16.72%
|
$60,401
$11.09 P/Share
|
|
Jun 13
2022
|
Craig A Collard Director |
BUY
Open market or private purchase
|
Direct |
4,037
+6.98%
|
$40,370
$10.94 P/Share
|
|
Jun 10
2022
|
Craig A Collard Director |
BUY
Open market or private purchase
|
Direct |
1,663
+3.23%
|
$18,293
$11.5 P/Share
|
|
Jun 09
2022
|
Michael Sinclair Director |
SELL
Open market or private sale
|
Direct |
7,896
-19.39%
|
$94,752
$12.25 P/Share
|
|
Jun 07
2022
|
Michael Sinclair Director |
SELL
Open market or private sale
|
Direct |
800
-1.93%
|
$9,600
$12.86 P/Share
|
|
Jun 06
2022
|
Michael Sinclair Director |
SELL
Open market or private sale
|
Direct |
7,688
-15.62%
|
$92,256
$12.94 P/Share
|
|
Jun 03
2022
|
Michael Sinclair Director |
SELL
Open market or private sale
|
Direct |
10,264
-17.26%
|
$133,432
$13.59 P/Share
|
|
Jun 02
2022
|
Brian Gorman |
SELL
Open market or private sale
|
Direct |
1,148
-3.42%
|
$14,924
$13.52 P/Share
|
|
Jun 02
2022
|
Michael Sinclair Director |
SELL
Open market or private sale
|
Direct |
9,736
-14.07%
|
$126,568
$13.88 P/Share
|
|
May 16
2022
|
Craig A Collard Director |
BUY
Open market or private purchase
|
Direct |
27,150
+36.07%
|
$352,950
$13.54 P/Share
|
|
May 16
2022
|
Gabrielle Alison Silver Director |
BUY
Open market or private purchase
|
Direct |
2,500
+10.49%
|
$32,500
$13.29 P/Share
|
|
May 13
2022
|
Ann L. Mac Dougall Director |
BUY
Open market or private purchase
|
Direct |
3,000
+10.28%
|
$30,000
$10.93 P/Share
|
|
May 13
2022
|
Craig A Collard Director |
BUY
Open market or private purchase
|
Direct |
3,689
+14.96%
|
$36,890
$10.49 P/Share
|